Genocea Biosciences reported $59K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US USD 2.95M 120K
Baxter International BAX:US USD 683M 0
Bluebird Bio BLUE:US USD 829K 94K
Cytokinetics CYTK:US USD 93K 8K
Cytori Therapeutics CYTX:US USD 32K 10K
Genocea Biosciences GNCA:US USD 59K 1000
Glaxosmithkline GSK:US GBP 1.5B 136.72M
Infinity Pharmaceuticals INFI:US USD 89K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Moderna Inc MRNA:US USD 38.7K 500
Novavax NVAX:US USD 792K 4K